Hypha Labs (FUNI) Net Income towards Common Stockholders (2010 - 2026)
Hypha Labs (FUNI) reported Net Income towards Common Stockholders of -$521114.0 for Q1 2026, up 18.81% on a YoY basis from -$438622.0 in Q1 2025, and little changed quarter-over-quarter from -$521638.0 in Q4 2025.
Hypha Labs (FUNI) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Hypha Labs has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$521114.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 18.81% year-over-year to -$521114.0; the trailing twelve-month figure through Mar 2026 stood at -$2.2 million (down 9.17% YoY), and the FY2025 full-year result was -$3.1 million, down 630.1% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$521114.0, roughly flat from -$521638.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $293533.0 in Q2 2023, with the low at -$1.3 million in Q4 2024.
- Historically, Net Income towards Common Stockholders has averaged -$339482.5 across 5 years, with a median of -$521114.0 in 2026.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 2152.61% — and 2024, when it surged 533.39%.
- Hypha Labs' Net Income towards Common Stockholders stood at -$240330.0 in 2022, then jumped by 221.76% to $292627.0 in 2023, then sank by 557.8% to -$1.3 million in 2024, then surged by 61.06% to -$521638.0 in 2025, then advanced by 0.1% to -$521114.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$521114.0 (Q1 2026), -$521638.0 (Q4 2025), and -$558415.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 141.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Hypha Labs | - | - | - | -521,114.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -521,114.00 |
| Dec 31, 2025 | -521,638.00 |
| Sep 30, 2025 | -558,415.00 |
| Jun 30, 2025 | -562,023.00 |
| Mar 31, 2025 | -641,822.00 |
| Dec 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | 292,529.00 |
| Dec 31, 2023 | 292,627.00 |
| Sep 30, 2023 | 261,069.00 |
| Jun 30, 2023 | 293,533.00 |
| Mar 31, 2023 | -67,498.00 |
| Dec 31, 2022 | -240,330.00 |
| Sep 30, 2022 | -829,186.00 |
| Jun 30, 2022 | -576,733.00 |
| Mar 31, 2022 | -373,596.00 |
| Dec 31, 2021 | -469,757.00 |
| Sep 30, 2021 | -319,837.00 |
| Jun 30, 2021 | -177,214.00 |
| Mar 31, 2021 | 18,201.00 |
| Dec 31, 2020 | -390,637.00 |